Mohammad Azab insider trades

Open-market stock purchases and sales by Mohammad Azab, Director at Lisata Therapeutics, Inc, from SEC Form 4 filings since Mar 11, 2010.

Recent trades

DateStockTradeValue
Jan 9, 2026LSTA Lisata Therapeutics, IncBought (not open market)—

Companies traded

  • LSTA Lisata Therapeutics, Inc: other filings, last Jan 9, 2026
  • DRRX Durect Corp: 6 buys, last Sep 11, 2025
  • XENE Xenon Pharmaceuticals Inc: 5 buys, 1 sale, last Dec 19, 2023
  • ASTX Astex Pharmaceuticals, Inc: other filings, last Oct 11, 2013
  • SUPG Supergen Inc: other filings, last Mar 24, 2011

Get free alerts when Mohammad Azab files a new trade →